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Ankrd2 is a modulator of NF-jB-mediated
inflammatory responses during muscle differentiation
C Bean*,1,8, NK Verma1,8, DL Yamamoto2, F Chemello1, V Cenni3, MC Filomena4,5, J Chen6, ML Bang*,5,7 and G Lanfranchi*,1
Adaptive responses of skeletal muscle regulate the nuclear shuttling of the sarcomeric protein Ankrd2 that can transduce
different stimuli into specific adaptations by interacting with both structural and regulatory proteins. In a genome-wide
expression study on Ankrd2-knockout or -overexpressing primary proliferating or differentiating myoblasts, we found an inverse
correlation between Ankrd2 levels and the expression of proinflammatory genes and identified Ankrd2 as a potent repressor of
inflammatory responses through direct interaction with the NF-jB repressor subunit p50. In particular, we identified Gsk3b as a
novel direct target of the p50/Ankrd2 repressosome dimer and found that the recruitment of p50 by Ankrd2 is dependent on Akt2-
mediated phosphorylation of Ankrd2 upon oxidative stress during myogenic differentiation. Surprisingly, the absence of Ankrd2
in slow muscle negatively affected the expression of cytokines and key calcineurin-dependent genes associated with the slow-
twitch muscle program. Thus, our findings support a model in which alterations in Ankrd2 protein and phosphorylation levels
modulate the balance between physiological and pathological inflammatory responses in muscle.
Cell Death and Disease (2014) 5, e1002; doi:10.1038/cddis.2013.525; published online 16 January 2014
Subject Category: Immunity
Ankyrin repeat domain protein 2 (Ankrd2/Arpp) belongs to
the muscle ankyrin repeat protein (MARP) family, whose
members are involved in muscle stress response pathways.1
In addition to a well-documented role of Ankrd2 in
mechanotransduction,2–6 we previously demonstrated a role
of Ankrd2 in coordinating proliferation and apoptosis during
myogenic differentiation,7 which we found to be dependent on
Akt2-mediated phosphorylation at Ser-99 in response to
oxidative stress.8 Although the binding of Ankrd2 to numerous
nuclear and cytoplasmic proteins9 suggests its involvement in
various signaling pathways, its functional significance has
remained elusive. Based on ablation and overexpression of
Ankrd2 in differentiating primary myoblasts and C2C12 cells,
we demonstrate that Ankrd2 plays an important role in
modulating NF-kB transcriptional activity through direct
interaction with the NF-kB repressor p50. NF-kB is a
transcription factor composed of homo- and heterodimers,
affecting the expression of more than 150 genes related to
inflammatory and cell survival responses.10 Tight regulation of
NF-kB target genes is essential for ensuring the appropriate
induction and subsequent resolution of inflammation and
fluctuations in the levels of NF-kB-dependent cytokines
establish whether the effects of inflammatory signaling
pathways are beneficial or detrimental.11 Rapid resolution of
inflammation is ensured by the NF-kB-specific inhibitor IkBa.12
Furthermore, several additional regulatory checkpoints
regulate NF-kB activity. In particular, the p50 subunit was
recently shown to play a predominant role in the suppression
of inflammation during the later stages of NF-kB activation
through the formation of specific NF-kB complexes.13 As p50
lacks a transactivation domain, its influence on transcription is
dependent on dimerization with other members of the NF-kB
family or on different coregulators.13–15 Here we show that
Ankrd2 recruits p50, dominating over p65/p50 dimers, and
orchestrates the repression of inflammation-related genes
during muscle differentiation. As a direct target of the novel
p50/Ankrd2 dimer, we have identified Gsk3b that has
emerged as an important player for both generation and
resolution of inflammatory responses.16–18 Another important
regulator of NF-kB function is the intracellular redox state.
Reactive oxygen species (ROS) activate NF-kB and enhance
the expression of pro-inflammatory genes, such as TNFa, IL6,
and C-reactive protein, which are involved in the pathogenesis
of inflammation.19 Pro-inflammatory cytokines, in turn, stimu-
late the production of ROS that have thus been proposed as
universal second messengers of the NF-kB activation path-
way.20 Cells possess several defense systems to protect
against the harmful effects of ROS. Here we propose a novel
molecular mechanism by which activation of Akt2 leads
to the resolution of oxidative stress and inflammation via
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Ankrd2-dependent NF-kB inhibition. Unexpectedly, the
absence of Ankrd2 in slow muscle in vivo was associated
with decreased expression levels of cytokines and key
calcineurin-dependent genes, involved in the maintenance
of the slow-twitch muscle program. Thus, as muscles produce
cytokines both constitutively and in response to various
inflammatory stimuli,21,22 our findings suggest a multifaceted
role of Ankrd2 in inflammatory signaling pathways.
Results
Inverse correlation between Ankrd2 levels and the
expression of pro-inflammatory genes. To study the role
of Ankrd2, we took advantage of the Ankrd2 knockout (KO)
mouse model (Supplementary Figure S1)23 and performed
global transcriptome analysis on proliferating, fusing, and
differentiated primary myoblasts derived from wild-type (WT)
and KO mice infected with adenovirus expressing HA-tagged
Ankrd2 (AdAnkrd2) or control GFP (AdGFP). Quantitative
real-time PCR (qRT-PCR) and western blot analyses
showed highly efficient gene transfer of Ankrd2
(Supplementary Figures S2a and b). Gene expression
profiles of differentiating myoblasts after deletion, rescue,
or overexpression of Ankrd2 were obtained as outlined in
Supplementary Figure S2c and the complete lists of altered
genes can be found in Supplementary Datasets S1, S2, and
S3, respectively. As shown in Figures 1a and b and in
Supplementary Table S1, the most affected gene network
was associated with inflammatory and immune responses.
As Ankrd2 is expressed at increasing levels during differ-
entiation, the major transcriptional changes were found in
Ankrd2 KO myotubes, where the expression of many crucial
Figure 1 Ankrd2 protein levels affect the expression of NF-kB-related genes. (a) KEGG pathway enrichment analysis for up- and down-regulated genes in fully
differentiated myoblasts from AdGFP-infected Ankrd2 KO cells compared with WT. A total of 2291 differentially genes (1381 upregulated and 910 downregulated) were
identified by unpaired two-class significance analysis of microarray (SAM) analysis with a false discovery rate (FDR) of 0%. Only selected pathways with the most significant
changes are shown (Po0.1). (b) KEGG pathway enrichment analysis for up- and downregulated genes in AdAnkrd2- compared with control AdGFP-infected Ankrd2 KO cells
at different stages. Three sets of unpaired two-class SAM analyses showed that Ankrd2 overexpression resulted in differential expression of a total of 48, 197, and 235 unique
transcripts in proliferating, fusing, and differentiated Ankrd2 KO myoblasts, respectively (0% FDR). (c) Gene expression heat map for the functional annotated transcripts that
are differentially expressed (0% FDR) at all differentiation stages in response to acute overexpression of Ankrd2 in Ankrd2 KO cells and the relative pie chart showing the
KEGG pathway enrichment analysis. The value in each sector represents the number of deregulated genes. (d) Identification of transcription factor binding sites (TFBSs)
present in the DE genes by oPOSSUM, showing a significant enrichment for NF-kB-binding sites
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NF-kB-inducible genes, including the pro-inflammatory cyto-
kines Tnfa, Il1b, and Il6, was increased (see Supplementary
Dataset S1). Conversely, these genes were downregulated
by Ankrd2 overexpression (see Supplementary Datasets S2
and S3), which affected the expression of 69 transcripts
related to inflammation, having NF-kB as a central node
(Figure 1c). Consistent with a role of Ankrd2 as a negative
regulator of NF-kB-directed inflammation, a specific enrich-
ment for NF-kB-binding motifs was found in the set of
downregulated genes in Figure 1c using the oPOSSUM tool
(Figure 1d).
Ankrd2 inhibits NF-jB transcriptional activity. To deter-
mine the effect of Ankrd2 on NF-kB activity, myogenic
C2C12 cells were cotransfected with a NF-kB reporter vector
containing a triplicate NF-kB-responsive element driving a
firefly luciferase reporter (3NF-kB-luc) and Renilla
luciferase vector (pGL4.74) as normalization control before
infection with AdAnkrd2 or control AdGFP. NF-kB activity
increased during myogenic differentiation, but was repressed
by Ankrd2 at all stages (Figure 2a), identifying Ankrd2 as a
negative regulator of NF-kB. We recently demonstrated that
under hydrogen peroxide-induced stress triggering the
production of ROS, Akt2 phosphorylates Ankrd2 at Ser-99,
inducing its nuclear translocation and inhibition of muscle
differentiation.8 To determine whether Akt2-dependent
Ankrd2 phosphorylation mediates NF-kB regulation, C2C12
myoblasts were cotransfected with the 3NF-kB-luc reporter
vector and FLAG-tagged WT or Ser99Ala mutant human
Ankrd2. As shown in Figure 2b, WT Ankrd2, but not
nonphosphorylatable Ser99Ala-Ankrd2, inhibited NF-kB
activity both during proliferation and differentiation,
Figure 2 Ankrd2 represses the transcriptional activity of NF-kB during oxidative stress. (a) C2C12 myoblasts were transfected with the 3NF-kB-luc vector and pGL4.74
control vector before infection with AdAnkrd2 or AdGFP. The values represent the firefly/Renilla luciferase ratio in proliferating and differentiating cells. (b) Luciferase activity
assay in C2C12 cells following cotransfection of 3NF-kB-luc vector with FLAG-tagged WT or Ser99Ala mutant (S99A) Ankrd2. (c) Effect of 4 h of treatment with hydrogen
peroxide on NF-kB transcriptional activity in C2C12 myoblasts at 1 day after induction of differentiation. Where indicated, cells were pretreated with Akt1/2- and Akt-specific
inhibitors, as previously described.8 (d) Western blot analyses on the same samples as in (c), showing increased phosphorylation levels of Akt and Ankrd2. MB, myoblast;
MT, differentiating myotubes at 1, 3, and 6 days (d) after induction. Data are represented as mean±S.D. (n¼ 3). *Po0.05; **Po0.01
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demonstrating that Akt can inhibit NF-kB-regulated inflam-
matory genes via phosphorylation of Ankrd2 and suggesting
a role of Ankrd2 as a sensor of the oxidative state through
impairment of NF-kB activation. To determine whether Akt
exerts an inhibitory effect on NF-kB in a ROS- and Ankrd2-
dependent manner during muscle differentiation, we studied
the effect of hydrogen peroxide treatment and found
increased phosphorylation levels of Akt and Ankrd2 and
consequent decreased NF-kB luciferase activity (Figures 2c
and d). As expected, inhibition of Akt led to dephosphoryla-
tion of Ankrd2, but a decrease in NF-kB activity, consistent
with the well-established role of Akt in promoting NF-kB
transcriptional activity.24,25 Our results, revealing a novel
mechanism by which Akt-dependent Ankrd2 phosphorylation
negatively regulates NF-kB during oxidative stress, suggest
for the first time that Akt can act both positively and
negatively on the NF-kB pathway.
Ankrd2 interacts and colocalizes with the NF-jBmember
p50. Based on the striking similarity between Ankrd2 and the
NF-kB inhibitor I-kB,26 we hypothesized that Ankrd2 may
modulate NF-kB activity through direct interaction. To test
the ability of Ankrd2 to bind to the two main subunits of
NF-kB, p65 or p50, we transfected C2C12 cells with
FLAG-tagged human WT Ankrd2 and performed immuno-
precipitation (IP) using anti-FLAG-tag antibody, followed by
western blot analysis for p50 and p65. This revealed the
binding of Ankrd2 to p50, but not p65 (Figure 3a), which was
confirmed by a reverse experiment, showing the ability of p50
to immunoprecipitate Ankrd2 (Figure 3b). FLAG-tagged
Ser99Ala-mutant Ankrd2 failed to co-immunoprecipitate
p50, demonstrating that phosphorylation of Ser-99 is critical
for the Ankrd2–p50 interaction.
To identify the cellular compartment where p50 interacts
with Ankrd2, we investigated the localization of endogenous
Ankrd2 during proliferation and differentiation. In proliferating
and early differentiating C2C12 cells, colocalization of Ankrd2
and p50 in structures resembling promyelocytic leukemia
(PML) nuclear bodies (NBs)27 was found (Figure 3c, panels I
and II). However, upon advancing differentiation, Ankrd2
moved to the cytoplasm and colocalization was lost, except in
few cells where Ankrd2 was still present in the NBs (Figure 3c,
panels III and IV). As we observed repression of NF-kB by
exogenous Ankrd2 protein in terminally differentiated
myotubes where endogenous Ankrd2 and p50 do not
colocalize, we stained AdAnkrd2-infected C2C12 myotubes
with anti-HA antibody to detect exogenous Ankrd2. As shown
in Supplementary Figure S3, when overexpressed, Ankrd2
translocates to the nucleus where it may interact with p50 and
inhibit NF-kB activity, thereby regulating inflammation-related
genes.
Gsk3b is transcriptionally regulated by the Ankrd2/p50
complex. To validate the Ankrd2/p50 complex as a novel
repressor, we searched for putative targets among genes
whose expression levels were anticorrelated with that of
Ankrd2. Interestingly, the only gene that was strongly
downregulated upon overexpression of Ankrd2 at all stages
was Gsk3b, a powerful governor of inflammatory signaling
(Figure 4a). Western blot analysis confirmed the decrease in
GSK3b protein and phosphorylation levels (Figure 4b),
suggesting that the inhibition of NF-kB signaling by Ankrd2
overexpression may be reinforced through the Gsk3b
pathway.28 These results were confirmed in C2C12 cells
where infection with AdAnkrd2 resulted in decreased
phosphorylation of Gsk3b at all stages (Figure 4c), whereas
the protein level was significantly reduced only in fully
differentiated cells (Figure 4c). Overexpression of Ser99-
Ala-mutant Ankrd2 had no effect on Gsk3b phosphorylation
(Figure 4d), demonstrating that the effect of Ankrd2 on
Gsk3b activity is dependent on its phosphorylation by Akt2.
These results identify Gsk3b as a downstream target
of the anti-inflammatory signaling cascade activated by
Akt2-phosphorylated Ankrd2.
Using the Genomatix and Patch tools, we identified several
putative binding sites for NF-kB transcription factors in the
Gsk3b upstream promoter region (Figure 5a). To determine
whether Ankrd2 and NF-kB are recruited to the Gsk3b
promoter, chromatin immunoprecipitation (ChIP) was per-
formed on proliferating and differentiated C2C12 cells using
antibodies against Ankrd2, p50, or p65, after which the
captured genomic DNA was analyzed by qRT-PCR using
primers spanning the Gsk3b promoter. As shown in Figures
5b and c, specific binding sites for Ankrd2 and p50 were found
within the Gsk3b promoter. To functionally validate these
interactions, C2C12 cells were cotransfected with a luciferase
reporter construct containing selected Ankrd2- and p50-
binding sites within the Gsk3b promoter and expression
vectors encoding FLAG-tagged WT or Ser99Ala mutant
human Ankrd2 or empty expression plasmid as a negative
control. Cotransfection with WT Ankrd2 caused significant
repression of Gsk3b promoter activity, whereas mutant
Ankrd2 resulted in a much lower repression (Figure 5d).
Thus, the complex formed by p50 and phosphorylated Ankrd2
can repress Gsk3b through direct binding to its promoter in an
Akt2-phosphorylation-dependent manner.
p50 regulates the expression of Ankrd2 in a classic
feedback inhibition way. Ankrd2 was recently shown to be
activated by longitudinal stretch through the recruitment of
the NF-kB heterodimer p50/p65 to the Ankrd2 promoter that
contains two putative NF-kB-binding sites.29 To investigate
whether the NF-kB boxes are functional, we performed ChIP
on proliferating and fully differentiated C2C12 myoblasts
using antibodies against p50 and p65. The relative
occupancy of the boxes (referred to as proximal and distal
NF-kB box according to their position relative to the
transcription start site) was determined by qRT-PCR using
specific primers encompassing the NF-kB-binding sites. Our
results showed strong binding of p50 to both the proximal
and distal NF-kB boxes in myoblasts, whereas in differen-
tiated cells, reduced binding to the proximal box and a
complete abrogation of binding to the distal box was found
(Figure 6a). Interestingly, only weak binding of p65 to the
NF-kB boxes in the Ankrd2 promoter was detected in both
myoblasts and differentiated cells, again with a reduction to
baseline for the distal box in myotubes.
To investigate the functionality of the two NF-kB boxes
within the Ankrd2 promoter, we performed a series of
luciferase assays with the constructs shown in Figure 6b.
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Figure 3 Ankrd2 interacts and colocalizes with p50. (a) IP of Ankrd2 following transfection of C2C12 cells with FLAG-tagged WT or Ser99Ala mutant Ankrd2. Ankrd2 is
able to interact with p50, but not with p65. Moreover, Ankrd2 Ser99Ala does not bind to p50, demonstrating that Ankrd2 phosphorylation is essential for p50 binding.
(b) Reverse experiment confirming the interaction between Ankrd2 and p50: IP of p50 following transfection of C2C12 cells with FLAG-tagged p50. (c) Immunostainings of
proliferating and differentiating C2C12 cells for Ankrd2 and p50. Both proteins were visible in a speckled pattern in the nuclei of proliferating and early differentiating myoblasts
(panel I at two different magnifications and panel II). With progressive differentiation, Ankrd2 became almost completely cytoplasmic and did not colocalize with p50 (panels III
and IV at two different magnifications). MB, proliferating myoblasts, MT, differentiating myotubes at 1, 3, and 6 days (d) after induction
Crosstalk between Ankrd2 and NF-jB in muscle
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The shortPROwtluc vector contains 317 bp upstream of the
Ankrd2 ATG start codon spanning two paired E-boxes and the
proximal NF-kB box. The longPROwtluc construct ( 663 bp
upstream of ATG) also includes the distal NF-kB box. Mutant
reporters with deletion of the proximal box (shortPRO-NF-
kBluc and longPRO-NF-kBluc) were obtained by site-directed
mutagenesis. The reporter gene activity for each construct
was measured in both proliferating and differentiated myo-
blasts as summarized in Figure 6c. Consistent with our
previous data,7 both WT constructs resulted in increased
luciferase activity and thus increased Ankrd2 expression
during differentiation. On the other hand, activation of
Figure 4 Ankrd2 decreases the Gsk3b protein expression level and inhibits its activity. (a) Heat map of gene expression values for Ankrd2 and Gsk3b in proliferating
(stage 1), fusing (stage 2), and differentiated (stage 3) primary myoblasts derived from Ankrd2 KO and WT mice infected with AdAnkrd2 or control AdGFP (n¼ 3).
(b) Representative western blot showing Gsk3b protein and phosphorylation levels at the same stages as in (a). (c) Western blot analysis for Ankrd2 and Gsk3b protein and
phosphorylation levels on lysate from proliferating and differentiating C2C12 myoblasts infected with AdAnkrd2 or AdGFP. Densitometry analysis for total and phosphorylated
Gsk3b normalized to b-actin protein levels was performed. (d) Western blot and relative densitometry analysis of active and total Gsk3b normalized to b-actin protein levels
from proliferating and differentiating C2C12 cells transfected or not with WT or Ser99Ala mutant (S99A) Ankrd2. MB, proliferating myoblasts, MT, differentiating myotubes at 1
and 6 days (d) after induction. Data are represented as mean±S.D. (n¼ 3). *Po0.05; **Po0.01
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luciferase activity by the shortPROwtluc vector was about
three times stronger than by the longPROwtluc construct,
suggesting that a transcription factor may bind to the distal
region of the Ankrd2 promoter negatively regulating its
expression. Bioinformatic analysis suggested NF-kB as a
repressor of the Ankrd2 promoter,29 which is consistent with
our finding that p50 can directly bind to the Ankrd2 promoter
and the fact that p50 lacks a transactivation domain and thus
is mainly associated with transcriptional repression.30 These
data, together with our finding that deletion of the proximal
NF-kB regulatory element strongly increases Ankrd2-driven
luciferase expression, suggest that the p50/p50 homodimer
acts as a transcriptional repressor of Ankrd2 expression by
binding its promoter.
It is well known that treatment of cells with proinflammatory
cytokines (TNFa and IL1b), or bacterial lipopolysaccharides
(LPS), leads to degradation of I-kB, allowing p50/p65 dimers
to translocate to the nucleus and act as transcription
factors.31 Consistent with this, activation of NF-kB by LPS
was confirmed by an approximately twofold increase in
luciferase activity in LPS-treated proliferating and differen-
tiating C2C12 cells transfected with the NF-kB reporter
vector (Supplementary Figure S4). Therefore, to study the
effect of NF-kB activation on Ankrd2 expression, proliferat-
ing and differentiating C2C12 myoblasts transfected with the
different luciferase constructs were treated with LPS. As
shown in Figure 6d, luciferase activity was repressed
following LPS treatment independent from the deletion of
the proximal NF-kB box, suggesting that the p50/p65 dimer
is not involved in the regulation of Ankrd2 expression. We
have previously shown that Ankrd2 expression is under the
control of MyoD,32 which is downregulated in response to
Figure 5 Ankrd2 regulates the transcription of Gsk3b. (a) Schematic representation of putative NF-kB-binding elements within the Gsk3b promoter identified using
Genomatix and Patch software. The white bars depict the regions of the Gsk3b promoter amplified by primer sets covering the putative NF-kB response elements. The Gsk3b
luciferase reporter construct is represented on the bottom. (b) Using anti-Ankrd2 antibody, ChIP was performed on nuclear extracts from proliferating and differentiating C2C12
myoblasts. qRT-PCR was performed on input and immunoprecipitated DNA with the Gsk3b promoter-specific primers shown in (a). The bars represent the fold enrichment of
Ankrd2 occupancy of the Gsk3b promoter relative to that of control IgG samples. (c) ChIP was performed using anti-p50 and anti-p65 antibodies followed by qRT-PCR
analysis as described in (b). (d) Luciferase activity assay following cotransfection of C2C12 cells with a luciferase reporter plasmid encoding the identified Ankrd2 and
p50-binding region within the Gsk3b promoter (765 bp, (a)) and WT or S99A mutant Ankrd2. pGL4.74 was used for normalization of transfection efficiency. MB, proliferating
myoblasts, MT, differentiating myotubes at 1, 5, and 6 days (d) after induction. All data are represented as mean±S.D. (n¼ 3). *Po0.05; **Po0.01
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TNFa-induced NF-kB activation.33 Consistently, a ChIP
assay revealed direct binding of MyoD to the Ankrd2
promoter (Figure 6e). Moreover, transfection with the short-
PRO-MyoDluc vector in which the MyoD-binding site was
deleted resulted in a 2.7-fold reduction in luciferase activity
as compared with the WT construct (Figure 6f), demonstrat-
ing that the Ankrd2 promoter is positively regulated by MyoD.
Thus, the inhibition of the Ankrd2 promoter following LPS
treatment during myoblast differentiation may be because of
degradation of the Ankrd2 transcriptional activator MyoD at
both the mRNA and protein levels, induced by activation
of the canonical NF-kB pathway.33 This hypothesis is
supported by the fact that the luciferase activity of the
shortPRO-MyoDluc vector was not repressed following LPS
treatment (Figure 6f).
Ankrd2 affects the expression of inflammatory cytokines
in vivo. Our experiments on differentiating mouse primary
and C2C12 myoblasts demonstrate a complex role of Ankrd2
in the pathways modulating inflammatory responses. To
determine whether Ankrd2 may affect cytokine expression
in vivo, mRNA and protein levels of NF-kB-regulated genes
were determined by qRT-PCR and western blot analyses on
slow oxidative soleus and fast glycolytic extensor digitorum
longus (EDL) muscles from WT and Ankrd2 KO mice.
Consistent with the previously reported preferential
Figure 6 Ankrd2 expression is negatively and positively regulated by p50 and MyoD, respectively. (a) ChIP with antibodies against p50 and p65 was performed on nuclear
extracts from proliferating and differentiating C2C12 cells followed by qRT-PCR using primers spanning the putative NF-kB-binding elements. The bars represent the fold
enrichment of p50 and p65 occupancy of the Ankrd2 promoter relative to that of control IgG samples. (b) Graphical representation of the 50-mouse Ankrd2 promoter region and
the conserved portions in the constructs used for transfection experiments. (c) Luciferase activity assay following cotransfection of C2C12 cells with the first four luciferase
constructs in (b) and the pGL4.74 control vector. (d and f) Luciferase activity assay in LPS-treated (2 mg/ml LPS for 24 h) compared with untreated cells transfected with the
reporter vectors in (b). (e) Following cotransfection of HEK293A cells with FLAG-tagged MyoD and Ankrd2 promoter-driven luciferase vectors, ChIP was performed using anti-
FLAG antibody. The immunoprecipitates were analyzed by standard PCR (top) and qRT-PCR (bottom) using specific primers for amplifying regions within the Ankrd2 promoter
region containing the proximal or distal MyoD-binding site or both. IPed chromatin from HEK293A cells transfected with FLAG-tagged empty vector (IP mock) represents the
negative control. The enrichment of each specific region of the Ankrd2 promoter compared with mock IP DNA was determined by qRT-PCR. All data are represented as
mean±S.D. (n¼ 3). MB, proliferating myoblasts, MT, differentiating myotubes at 1, 2, and 5 days (d) after induction. *Po0.05; **Po0.01
Crosstalk between Ankrd2 and NF-jB in muscle
C Bean et al
8
Cell Death and Disease
expression of Ankrd2 in slow-twitch fibers,34 Ankrd2 was
expressed at higher amounts in soleus compared with EDL
muscle (Figure 7a and Supplementary Figure S5). Further-
more, knockout of Ankrd2 was not compensated for by
upregulation of other MARP family members (Figure 7a).
Unexpectedly, decreased transcript levels of Il6, Tnfa, and
IkBa were found in soleus muscle in the absence of Ankrd2
(Figure 7b), although Akt, Gsk3b, and NF-kB activities were
similar between WT and Ankrd2 KO mice (Supplementary
Figure S5). As NF-kB activity is physiologically higher in slow
than in fast muscle35 (Supplementary Figure S5), we
investigated whether Ankrd2 deletion may make muscle
prone to fiber-type switching by changing the muscle
transcriptional signature. As shown in Figure 7c, although
skeletal muscle from Ankrd2 KO mice appeared morpholo-
gically equal to WT muscle and no significant changes in
fiber-type distribution were found,23 the slow gene expres-
sion program was significantly modified. In particular, the
calcineurin-dependent genes, Il6, Glut4, and Rcan1,36–38
were significantly downregulated in soleus muscle from
Ankrd2 KO mice. Thus, our in vivo results suggest a role of
Ankrd2 in the regulation of basal inflammatory cytokine
production in a fiber type-dependent manner.
Discussion
Ankrd2 is strongly and rapidly upregulated under different
muscle stress conditions, but the reason for this response has
remained unclear. To explore gene networks that are
disturbed by changes in Ankrd2 levels, we performed
genome-wide expression analyses on proliferating and
differentiating primary myoblasts derived from WT and
Ankrd2 KO mice infected with adenovirus overexpressing
Ankrd2 or control GFP. We chose to perform our study on
primary mouse myoblasts, as gene expression analysis on
whole muscle with nonhomogenous fiber composition is likely
to show only an averaged picture of the consequences of
Ankrd2 loss because of its fiber type-specific expression.33
Our analyses revealed that Ankrd2 negatively regulates the
expression of a large number of genes known to be involved in
inflammatory pathways mediated by NF-kB. NF-kB has been
shown to control myogenesis through its involvement in both
pro- and anti-myogenic pathways,39 and we here uncover a
novel NF-kB signaling axis involved in muscle differentiation.
More specifically, we establish Ankrd2 as an inhibitor of
NF-kB activity through its interaction with the repressive
NF-kB subunit p50 and inhibition of the expression of crucial
inflammation-related genes. This is consistent with its striking
sequence and structural similarity to I-kB, the specific NF-kB
inhibitor.26 Similarly, overexpression of the MARP protein
family member Ankrd1 resulted in decreased DNA binding of
the NF-kB subunit p65 through an unknown mechanism.40
p50 can operate either as a pro-inflammatory or a negative
regulator of NF-kB-directed inflammation depending on the
cofactors that interact with the complex on the DNA. Our
results reveal a role of Ankrd2 as a selective regulator of
p50/p50 NF-kB-responsive genes in muscle cells. In parti-
cular, we found colocalization of Ankrd2 and p50 in a speckled
intranuclear pattern, consistent with the presence of Ankrd2
in PML-NB multiprotein nuclear structures9 where transcrip-
tional factors (i.e., NF-kB) and cofactors (i.e., Ankrd2)
associate to regulate gene expression.27 This is interesting
as PML has been shown to repress the transactivating function
of NF-kB by recruiting p65 to PML-NBs and to interfere with the
binding of NF-kB to its cognate DNA recognition sequence.41 In
addition to upregulation of NF-kB target genes, Pparg and
other members of the PPAR pathway were found to be
downregulated in Ankrd2 KO cells. Activated PPARs can exert
anti-inflammatory activity in several cell types, including
skeletal muscle cells. In particular, PPARg was recently shown
to suppress cytokine-induced NF-kB transcriptional activity and
target gene expression independent of p65 nuclear transloca-
tion and DNA binding.42 Thus, our findings suggest that PPAR-
dependent inhibition of NF-kB activity may be mediated
through the recruitment of Ankrd2 as a transcriptional cofactor
of the NF-kB DNA complex.
Figure 7 Ankrd2 affects the expression of inflammatory genes in a fiber-type
specific manner in vivo. qRT-PCR analysis of (a) MARP family members, (b) NF-kB-
dependent, and (c) calcineurin-responsive genes in slow oxidative soleus and fast
glycolytic EDL muscle from 3-month-old WT and Ankrd2 KO mice. *Po0.05;
**Po0.01
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As a target of the Ankrd2/p50 repressor complex, we
identified Gsk3b, a crucial regulator of inflammatory
processes.43 Thus, Ankrd2 reinforces its anti-inflammatory
protection by negatively regulating the expression of Gsk3b,
which is required for the production of pro-inflammatory
cytokines, such as IL6, IL1, and TNFa.44 Consistently,
Gsk3b, Il6, Il1b, and Tnfa were all downregulated after Ankrd2
overexpression (see Supplementary Datasets S2 and S3). In
accordance with the paradigm: ‘Genes whose expression is
anti-correlated with those studied might include members of a
pathway whose action is opposed’,45 Gsk3b and Ankrd2 are
both substrates of Akt2, but have opposite effects on
myogenic differentiation. Under stress conditions triggering
the production of ROS, Akt2 phosphorylation of Ankrd2 at
Ser-99 causes its translocation to the nucleus where it
negatively regulates muscle differentiation.8 On the other
hand, Akt2 phosphorylation of Gsk3b causes its inactivation,
thereby removing its inhibitory effect on differentiation and
hypertrophy.46 We found that the inhibitory effect of the
Ankrd2/p50 complex on Gsk3b is dependent on Akt2-mediated
phosphorylation of Ankrd2 induced by hydrogen peroxide.
Based on our results, we propose a novel model in which
activation of Akt2 in response to oxidative stress counteracts
the toxic effects of ROS through inhibition of NF-kB activity via
the repressor complex Ankrd2/p50 (Figure 8). Thus, when
there is risk for tissue damage and resolution of inflammation
needs to be assured, Ankrd2 may represent an important
anti-inflammatory agent. This is particularly interesting as
Ankrd2 expression has been shown to be positively correlated
with physical exercise,3,4,47,48 which induces an anti-inflamma-
tory environment, counteracting the development of various
chronic diseases,49 including dementia, diabetes, cardiovas-
cular disease, stroke, and cancer. Thus, our results suggest a
role of Ankrd2 in the protective effect of exercise through its
ability to repress inflammatory responses.
Constitutively expressed inflammatory cytokines partici-
pate in the regulation of many important aspects of skeletal
muscle function, including regeneration, hypertrophy, and
whole body metabolism.11,50 For example, although a chronic
increase in the IL6 protein level is associated with pathological
conditions such as atrophy,51 contracting muscle also
produces and releases IL-6 to regulate glucose homeostasis.52
Our in vivo data suggest a further role of Ankrd2 in modulating
the basal expression of cytokines under physiological condi-
tions. In soleus muscle from Ankrd2 KO mice, calcineurin-
stimulated transactivation of cytokines was found to be
affected in a fiber type-specific manner as indicated by the
downregulation of the key calcineurin-responsive genes Il6,
Glut4, and Rcan1. This is particularly interesting as Ankrd2
mRNA is preferentially expressed in adult slow-twitch muscle
fibers,34 and although we found no significant differences in
fiber-type distribution between Ankrd2 KO and WT mice,23 our
data reveal that slow muscle fibers of Ankrd2 KO mice are
transcriptionally adapted to fiber-type switching toward a
faster phenotype. This may appear contradictory, but in fact
an increasing number of studies have shown mismatches in
the relative proportion of mRNA and protein expression levels
of myosin isoforms detected in slow–fast transitional fibers.53–55
The absent effect of Ankrd2 knockout on Akt, Gsk3b, and
NF-kB activities in vivo may be because of compensatory
mechanisms as the mouse model is a constitutive knockout.
This report provides a molecular mechanism for signal
integration between Ankrd2 and NF-kB pathways, contributing
to the understanding of the role of Ankrd2 as signaling
molecule in skeletal muscle. The novel anti-inflammatory role
of Ankrd2 through suppression of NF-kB transcription
suggests its potential use as a target for the development of
specific therapeutic strategies for combating inflammation in
muscle.
Materials and Methods
Plasmid constructs. WT and Ser99Ala mutant FLAG-tagged human Ankrd2
expression vectors have been described previously.8 Full-length mouse p50 was
amplified by PCR from mouse skeletal muscle cDNA using the primers: forward-
EcoRI (50-CGGAATTCCGGCATGGCAGACGATGATCCCTAC-30) and reverse-
SacII (50-ATCGCCGCGGCGCTAATGGGTGACCCCTGCGTT-30), digested with
EcoRI/SacII, and inserted into a N-terminal FLAG-tag mammalian expression
vector. The 3NF-kBluc reporter vector, containing a triplicate NF-kB response
element, was generated by subcloning from a 3NF-kB-bgal reporter vector
(kindly supplied by Professor Stefano Schiaffino, University of Padova, Padova,
Italy) into the pGL3basic reporter vector (Promega, Madison, WI, USA). Briefly, the
230 bp DNA sequence containing the triplicate NF-kB response element was
KpnI/HindIII excised from the 3NF-kBbgal plasmid and cloned into the same
restriction sites of the pGL3basic reporter vector. Two luciferase reporter
constructs were produced: shortPROwtluc and longPROwtluc containing 317 and
663 nucleotides upstream of the Ankrd2 ATG start codon, respectively. The
reverse primer PROHindIII (50-GGGAAGCTTCTGTTTCTGCAAGCCACAGGGC-30)
combined with shortPROXhoI (50-CCGCTCGAGAGCCAGTTCCCAGCACTGAGG
ACAC-30) and longPROXhoI (50-CCGCTCGAGCCTGAGCTCTTAAAACAACAC
TAG-30) were used for PCR amplification with Ankrd2 mouse genomic DNA as
template. The PCR products were HindIII/XhoI digested and cloned into the pGL3-
basic vector (Promega). Site-directed mutagenesis to remove the MyoD or the
NF-kB-binding sequence was performed to generate three mutant reporters:
shortPRO-MyoDluc, shortPRO-NF-kBluc, and longPRO-NF-kBluc. Oligonucleo-
tide primers containing the desired mutations (MyoD-deleted primer:
50-TGTCCGAGGTGAAGGAGTTGAGCTAGTAAGCTC-30 and NF-kB-deleted pri-
mer: 50- TGGCTTCCCATGCTCCCTGAGGTGAAGGTGACAG-30) were used to
amplify a mutation-containing replica of the WT plasmid. The PCR products were
treated with DpnI before transformation into the E. coli DH10B strain. For
generation of the luciferase reporter construct GSK3bPROluc, containing 765
nucleotides upstream of the ATG of the Gsk3b gene driving the firefly luciferase
gene, PCR was performed on mouse genomic DNA using the primers: forward:
50-CCGCTCGAGCGGTTGCCTGGTTCCCATCATG-30 and reverse: 50-GGGAAGFigure 8 Proposed model of a novel antioxidant defense system
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CTTGATGGCTCTTCTTGAATC-30. The PCR product was HindIII/XhoI digested
and cloned into the pGL3-basic vector (Promega). All plasmids were confirmed by
sequencing.
Generation of Ankrd2 KO mice. Genomic DNA was isolated from a
mouse 129-SVJ genomic DNA library (Stratagene, La Jolla, CA, USA), using full-
length Ankrd2 cDNA as a probe. The first 2 exons and half of exon 3 were
replaced by cDNA encoding lacZ and a pGK neo cassette, thereby bringing the
b-galactosidase cDNA under the control of the endogenous promoter while
ablating the endogenous Ankrd2 gene (Supplementary Information, Supplementary
Figure S1a). The targeting construct was verified by sequencing and linearized
before electroporation into 129-SVJ-derived ES cells at the Transgenic Core
Facility at the University of California, San Diego (La Jolla, CA, USA). ES clones
were screened for homologous recombination by EcoRI digestion of ES cell DNA
and Southern blot analysis (Supplementary Information, Supplementary Figure
S1b) with the probe shown in Supplementary Information, Supplementary Figure
S1a. Cells from two independent targeted ES cell clones were microinjected into
C57BL/B6 blastocysts and transferred into pseudopregnant mice. Male chimeras
resulting from the microinjections were mated to Black Swiss mice and gave rise to
germline transmitted heterozygous mice that were subsequently interbred to
generate homozygous mice. Offspring from intercrosses were genotyped by PCR
analysis using mouse tail DNA and WT and KO allele-specific primers. The
following primers were used: WT: sense: 50-AACTTCGAAGATCCGCTCCTGG-30;
reverse: 50-CATCAATGATCTCACGTCGCAG-30 and KO: sense: 50-CACACTG
GACAGGCCTCTTTCC-30; reverse: 50-AGATGAAACGCCGAGTTAACGC-30,
giving rise to a 228-bp band from the WT allele and a 770-bp band from the
KO allele. Successful ablation of the Ankrd2 gene was confirmed by northern
(Supplementary Information, Supplementary Figure S1c) and western blot
analyses (Supplementary Information, Supplementary Figure S1d) using
polyclonal antibodies against Ankrd2.1 All animal procedures were in full
compliance with the guidelines approved by the University of California San
Diego Animal Care and Use Committee and the Italian Ministry of Health.
Adenovirus production. The adenovirus expressing Ankrd2-HA was
created using the AdEasy strategy (Agilent Technologies, Santa Clara, CA,
USA). The HA-tagged mouse Ankrd2 cDNA was cloned into the pAdTrack
cytomegalovirus vector (Agilent Technologies). Subsequent steps were performed
according to the manufacturer’s instructions. The adenoviral vectors contain two
distinct promoters that independently drive the expression of the gene of interest
and GFP. The mock plasmid expresses only GFP.
Cell cultures, DNA transfection, and adenoviral infection. The
C2C12 mouse cell line was cultured as previously described.7 For infection,
C2C12 cells were incubated with adenovirus at a multiplicity of infection (MOI) of
250 in growth or differentiation medium. The human embryonic kidney cell line
(HEK293A) was cultured in DMEM supplemented with 10% heat-inactivated FBS.
Cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions. Primary myoblasts were isolated from
the limbs of 3-day-old neonatal WT and Ankrd2 KO mice using a protocol modified
from Brodie and Sampson.56 Briefly, skinned mouse limbs were collected from
neonatal pups, minced, and subjected to serial trypsinization (successive 25min
periods until all tissue was digested) in 0.05% trypsin solution B (Biological
Industries, Kibbutz Beit-Haemek, Israel) in PBS by continuous stirring at 371C.
Cells were collected by centrifugation at 1000 g for 5 min and resuspended in
DMEM containing 20% FBS. After 30min of preplating to remove fibroblasts, the
supernatant was filtered through a nylon mesh and 1.0 106 cells/well were
plated on collagen-coated six-well plates. Cells were proliferated in DMEM–high
glucose containing 20% FBS and at a confluency of 80–95%, cell differentiation
was induced by reducing serum levels to 2% horse serum. For adenoviral
infection, cells were incubated with AdGFP or AdAnkrd2 at an MOI of 500 for 4 h
in serum-free medium and collected 20 h after the initiation of infection. Adenovirus
treatment was performed at three different stages: (1) proliferating myocytes
at B50% confluency (proliferation stage); (2) proliferating myocytes at B90%
confluency before induction of differentiation (fusion stage); and (3) differentiating cells
3 days after the induction of differentiation (differentiated stage).
RNA extraction and gene expression analyses. All microarray data
are MIAME (Minimum Information About a Microarray Experiment) compliant. Raw
data, normalized data, and detailed protocols are available in the GEO database
(accession number GSE43500). Total RNA was isolated using TRIzol reagent
(Invitrogen) following the manufacturer’s protocol. A Nanodrop ND-1000 (Agilent
Technologies) was used for RNA quantification and the RNA 6000 Nano LabChip
kit (Agilent Technologies) was used for RNA quality control in conjunction with an
Agilent Bioanalyzer 2001. Only samples with an RNA Integrity Number (RIN)49
were included in the study. For sample labeling, 50 ng of RNA was amplified and
Cy3-labeled using the Low Input Quick Amp WT Labeling Kit, one-color (Agilent
Technologies), in the presence of RNA Spike-In controls, following the
manufacturer’s instructions. Briefly, RNA was mixed with 1ml WT primer and
2 ml Agilent One-Color RNA Spike-In (1 : 20 000 dilution, Agilent Technologies)
and denatured for 10min at 651C. First-Strand Buffer, DTT, dNTP mix, and
AffinityScript RNaseBlock mix were added and cDNA synthesis was carried out for
2 h at 401C. After 15min at 70 1C to inactivate the enzymes, complementary RNA
(cRNA) was generated using T7 RNA polymerase that amplifies target material
and incorporates Cy3-labeled CTP. Run-off in vitro transcription reactions
proceeded for 2 h at 401C and the linearly amplified cRNA was purified with
RNeasy mini columns (Qiagen, Hilden, Germany). For hybridization, fragmentation
of 600 ng of Cy3-labeled cRNA was performed using the Agilent Hybridization Kit
(Agilent Technologies) following the manufacturer’s instructions. Then, 40 ml of
hybridization mix, composed of equal volumes of fragmented cRNA and 2 GEx
Hybridization Buffer HI-RPM, was dispensed onto one of the eight subarrays of the
Agilent SurePrint G3 Mouse GE 8x60K Microarray (Agilent Technologies).
Incubation proceeded for 17 h at 651C at 10 r.p.m. in a Microarray Hybridization
Oven (Agilent Technologies). Finally, slides were washed for 1 min at 221C in
Wash Solution 1 and subsequently for 1min in Wash Solution 2, prewarmed to
371C (Agilent Technologies). Microarrays were scanned using a GenPix 4000B
Scanner (Agilent Technologies) for fluorescence detection at 3mm resolution. Data
were extracted from the scanned images using the Feature Extraction Software
(Agilent Technologies) that also performed intra-array data normalization. The
Expander software was applied to quantile normalize the complete series of
experiments.57 Mean values were calculated for multiple probes with the same
Agilent Probe ID. Differentially expressed genes were identified using the
Significance Analysis of Microarray (SAM) test58 in the MultiExperiment Viewer
(MeV, v4.8), a part of the TM4 Microarray Software Suite (Dana-Farber Cancer
Institute, Boston, MA, USA).59 Two different false discovery rates (FDRs) were
used: 0% (higher stringency) or 5% (lower stringency). KEGG pathway enrichment
analysis was performed using the DAVID web server (http://david.abcc.ncifcrf.gov/
home.jsp).60
Web-based-software. Enrichment of transcription factors in the promoter of
DE genes was accomplished by using the oPOSSUM tool (http://opossum.
cisreg.ca). To identify the occurrence and frequency of transcription factor binding
sequences in the Gsk3b promoter, Genomatix software (http://www.genomatix.de/
matinspector.html) and Patch tool (http://www.gene-regulation.com/cgi-bin/pub/
programs/patch/bin/patch.cgi) were used.
Co-immunoprecipitation. Protein extracts from C2C12 cells were trans-
fected with FLAG-tagged WT or Ser99Ala mutant human Ankrd2 or FLAG-tagged
mouse p50 and incubated overnight at 41C with anti-FLAG-tag antibody and resin
provided by the IP/Co-IP Kit (Pierce, Rockford, IL, USA). Subsequently,
immunoprecipitates were subjected to western blot analysis using antibodies
against p50 (sc-114, Santa Cruz, Santa Cruz, CA, USA), p65 (sc-109, Santa
Cruz), Ankrd2,26 and FLAG-tag.
Immunofluorescence microscopy. Proliferating (myoblasts) and differ-
entiating (myotubes) C2C12 cells were grown on collagen-coated coverslips, fixed
with 4% paraformaldehyde for 10min, and subsequently processed for
co-immunofluorescence staining using rabbit anti-p50 polyclonal antibody
(sc-114, Santa Cruz) and a mouse monoclonal antibody specific for the Ankrd2
N-terminus26 as previously described. The immunostained samples were observed
with a Leica (Solms, Germany) 5000 DFC300FX microscope at  40 and  100
magnifications.
Luciferase reporter assay. Luciferase reporter constructs were cotrans-
fected with a modified pGL4.74 control reporter vector (Promega) in mouse C2C12
cells. The pGL4.74 vector was mutated by deletion of the thymidine kinase
promoter to provide basal levels of Renilla luciferase expression in cotransfected
cells. At 6 h after transfection, the medium was replaced with growth or
differentiation-promoting medium and at 24, 48, and 144 h after transfection, cell
lysates were prepared from proliferating and differentiating myoblasts. Luciferase
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and Renilla activity were measured on a TD-20/20 Single-Tube Luminometer
(Turner BioSystems, Sunnyvale, CA, USA) using the Dual-Luciferase Reporter
Assay System (Promega). Luciferase activity was normalized to Renilla activity to
account for variations in transfection efficiency. Where indicated, transfected cells
were treated with 250mM H2O2 for 2, 4, and 6 h before collection. In some
experiments, 2mg/ml of LPS (Sigma-Aldrich, St. Louis, MO, USA) was added to
the cells 24 or 48 h after transfection, whereafter cell lysates were prepared
24 h later.
Chromatin immunoprecipitation assays. ChIP assays were carried
out using the ChIP assay kit (Millipore, Billerica, MA, USA) according to the
manufacturer’s instructions. C2C12 myoblasts and myotubes at the fourth day of
differentiation were fixed by adding formaldehyde solution into the culture medium
to a final concentration of 1%, rinsed twice with ice-cold PBS, and lysed according
to the manufacturer’s specifications. Sonication was performed on ice using a
Sonic Dismembrator Model 300 (Thermo Fisher Scientific, Waltham, MA, USA)
at a power of 50% for 3 cycles of sonication, each cycle for 30 s, followed by
a 10-s break on ice. Chromatin complexes were immunoprecipitated with
anti-Ankrd2, anti-p50, or anti-p65 antibodies and used as template for qRT-PCR.
The primer sequences used are listed in Supplementary Information, Supplementary
Table S2.
Real-time PCR. qRT-PCR based on SYBR Green chemistry (Finnzymes,
Vantaa, Finland) was carried out as described previously.7 The primer sequences
used are listed in Supplementary Information, Supplementary Table S3.
Protein extraction and western blot analysis. Total protein lysate
from C2C12 cells was extracted by solubilization in RIPA lysis buffer (50mM Tris,
pH 7.4, 150mM NaCl, 2 mM EDTA, 1% NP40, and 0.1% SDS) and protease
inhibitor cocktail (Sigma-Aldrich), whereas mouse muscle was homogenized in the
following lysis buffer: 50 mM Tris, pH 7.4, 150mM NaCl, 10mM MgCl2, 1 mM
EDTA, 10% glycerol, 0.5 mM DTT, 1% Triton X-100, 2% SDS, protease inhibitor
cocktail (Roche, Indianapolis, IN, USA), and phosphatase inhibitor cocktail
(Pierce). Western blot analyses were performed using antibodies against
Ankrd2,26 phospho-Ankrd28 (Cenni V et al., manuscript in preperation), Gsk3b,
phospho-Gsk3b (Ser-9), Akt, phospho-Akt (Ser-473), p65 and phospho-p65 (Ser-536),
b-tubulin (all from Cell Signaling, Danvers, MA, USA), and b-actin (Sigma-Aldrich).
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